News
Results One in three patients with high-titre GAD65 antibodies were classified as not having GAD65 neurological autoimmunity Of 323 patients with high-titre GAD65 antibodies, 37 (11%) had ...
Antibodies against SARS-CoV-2 provide protection against infection, but the virus has evolved to evade them. Here, the authors characterize a human antibody with incomplete neutralization of SARS ...
BeiGene abandons TIGIT antibody after lung cancer flop BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class.
Antibody therapy articles from across Nature Portfolio Antibody therapies are a type of biologic. They are typically monoclonal antibodies selected to bind to a particular protein (often a cell ...
FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results